Literature DB >> 26264573

Effects of agkistrodon in different dosage forms on collagen-induced arthritis in rats.

Jie Bao1, Zhi-Jun Xie1, Lei-Ming Chen1, Jing Sun2, Yong-Sheng Fan1.   

Abstract

OBJECTIVE: To determine the effective dosage and formulation of agkistrodon in collagen-induced arthritis (CIA) rats.
METHODS: CIA was induced by injection of collagen in complete/incomplete Freund's adjuvant. Agkistrodon decoction, agkistrodon powder, and agkistrodon wine were administered daily starting from the onset of arthritis. Paw swelling degree was measured by using a volume-measuring instrument every 7 days after primary immunization. Arthritis index was measured and calculated using the "five scoring method" every 7 days. The levels of serum interleukin-1ß (IL-1ß) and type II collagen IgG antibodies were detected by enzyme-linked immunosorbent assay. Finally, all ankles were removed, and X-ray radiography was performed with In-vivo Imaging System FX. Samples were counterstained with hematoxylin and eosin for analysis.
RESULTS: Among the various dosage formulations of agkistrodon, high-dose powder, which was equivalent to an amount of 6 g/day in adults, showed better effects on the inhibition of joint swelling and reduction of arthritis index score. The relatively low levels of serum IL-1 and anti-type II collagen IgG antibodies, as well as the X-ray radiography and pathology results, further proved the superiority of the high-dose powder over the other formulations. The effect of decoction on inhibiting joint swelling was inversely proportional to the dosage. Other effects, such as reduction of arthritis index score and the levels of serum IL-1 and anti-type II collagen IgG antibodies, were directly proportional to the dosage. While the use of large dose agkistrodon wine led to negative effects.
CONCLUSION: These data highlight the potential function of high-dose agkistrodon powder, which was equivalent to an amount of 6 g/day in adults. The powder can quickly relieve the symptoms of rheumatoid arthritis and prevent aggravation of disease, especially during the early period.

Entities:  

Keywords:  Chinese medicine; agkistrodon; collagen-induced arthritis; different dosage forms; rheumatoid arthritis

Mesh:

Substances:

Year:  2015        PMID: 26264573     DOI: 10.1007/s11655-015-2281-4

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  9 in total

1.  Low-dose ethanol aggravates allergic dermatitis in mice.

Authors:  Fumitoshi Sakazaki; Hirofumi Ogino; Tomohiro Arakawa; Tomofumi Okuno; Hitoshi Ueno
Journal:  Alcohol       Date:  2014-05-23       Impact factor: 2.405

Review 2.  How does Chinese medicine target cytokine imbalance in rheumatoid arthritis?

Authors:  Jian Liu; Yue Sun
Journal:  Chin J Integr Med       Date:  2013-10-30       Impact factor: 1.978

3.  Treatment with recombinant Hsp72 suppresses collagen-induced arthritis in mice.

Authors:  Xinjing Luo; Xiaoxia Zuo; Xuanrong Mo; Yaou Zhou; Xianzhong Xiao
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

4.  Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.

Authors:  Jochen Zwerina; Silvia Hayer; Makiyeh Tohidast-Akrad; Helga Bergmeister; Kurt Redlich; Ulrich Feige; Colin Dunstan; Giorgos Kollias; Günter Steiner; Josef Smolen; Georg Schett
Journal:  Arthritis Rheum       Date:  2004-01

5.  The widening mortality gap between rheumatoid arthritis patients and the general population.

Authors:  Angel Gonzalez; Hilal Maradit Kremers; Cynthia S Crowson; Paulo J Nicola; John M Davis; Terry M Therneau; Veronique L Roger; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2007-11

6.  CT20126, a novel immunosuppressant, prevents collagen-induced arthritis through the down-regulation of inflammatory gene expression by inhibiting NF-kappaB activation.

Authors:  Seon-Jin Lee; Woo-Dong Nam; Hee-Jun Na; Young-Lai Cho; Kwon-Soo Ha; Jong-Yun Hwang; Hansoo Lee; Soon-Ok Kim; Young-Guen Kwon; Young-Myeong Kim
Journal:  Biochem Pharmacol       Date:  2008-04-18       Impact factor: 5.858

Review 7.  Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.

Authors:  Charles A Dinarello; Anna Simon; Jos W M van der Meer
Journal:  Nat Rev Drug Discov       Date:  2012-08       Impact factor: 84.694

8.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

9.  Mediators of inflammation-induced bone damage in arthritis and their control by herbal products.

Authors:  Siddaraju M Nanjundaiah; Brian Astry; Kamal D Moudgil
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-07       Impact factor: 2.629

  9 in total
  1 in total

1.  Small Peptides Compound Isolated from Agkistrodon with Antiarthritic Effect in Collagen-Induced Arthritis Rats.

Authors:  Lijun Mei; Chen Lin; Shanshan Lei; Li Xu; Yong-Sheng Fan
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-29       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.